Merck & Co Inc

NYSE : MRK

$145.95+1.92%

Financials

Balance sheet · full history

USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.

Reported line item	Dec 31, 2018Balance date	Dec 31, 2019Balance date	Dec 31, 2020Balance date	Dec 31, 2021Balance date	Dec 31, 2022Balance date	Dec 31, 2023Balance date	Dec 31, 2024Balance date	Dec 31, 2025Balance date

Balance sheet, full reported history for 0000310158. USD in millions · per-share amounts unscaled. Each period shows the value from the latest filing that prints it.
Reported line item	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Cash and cash equivalents	7,965	9,676	8,050R	8,096	12,694	6,841	13,242	14,565
Short-term investments	899	774	0	0	498	252	447	0
Accounts receivable (net of allowance for doubtful accounts of $97 in 2025 and $89 in 2024)	7,071	6,778	6,803R	9,230	9,450	10,349	10,278	11,775
Inventories (excludes inventories of $5,681 in 2025 and $4,193 in 2024 classified in Other assets - see Note 7)	5,440	5,978	5,554R	5,953	5,911	6,358	6,109	6,658
Other current assets	4,500	4,277	4,674R	6,987	7,169	8,368	8,706	10,518
Total current assets	25,875	27,483	27,764	30,266	35,722	32,168	38,782	43,516
Current assets of discontinued operationsno longer reported			2,683	0
Investments	6,233	1,469	785	370	1,015	252	463	956
Land	333	343	336R	326	295	326	307	321
Buildings	11,486	11,989	11,998R	12,529	13,166	14,966	16,360	17,983
Machinery, equipment and office furnishings	14,441	15,394	15,860R	16,303	16,760	17,763	18,283	19,760
Construction in progress	3,355	5,013	6,968R	8,313	9,186	8,262	7,984	9,166
Property, plant and equipment (at cost)	29,615	32,739	35,162R	37,471	39,407	41,317	42,934	47,230
Less: accumulated depreciation	16,324	17,686	18,162R	18,192	17,985	18,266	19,155	21,914
Property, plant and equipment, net	13,291	15,053	17,000R	19,279	21,422	23,051	23,779	25,316
Goodwill	18,253	19,425	18,882R	21,264	21,204	21,197	21,668	21,579
Other Intangibles, Net	13,104R	14,196	14,101R	22,933	20,269	18,011	16,370	26,681
Other Assets	5,881R	6,771	9,881R	11,582	9,528	11,996	16,044	18,818
Total Assets	82,637	84,397	91,588	105,694	109,160	106,675	117,106	136,866
Noncurrent Assets of Discontinued Operationsno longer reported			3,175	0
Loans payable and current portion of long-term debt	5,308	3,610	6,431	2,412	1,946	1,372	2,649	2,589
Trade accounts payable	3,318	3,738	4,327R	4,609	4,264	3,922	4,079	4,404
Accrued and other current liabilities	10,151	12,549	12,212R	13,859	14,159	15,766	15,694	14,468
Income taxes payable	1,971	736	1,597R	1,224	1,986	2,649	3,914	4,726
Dividends payable	1,458	1,587	1,674	1,768	1,884	1,985	2,084	2,140
Total current liabilities	22,206	22,220	27,327	23,872	24,239	25,694	28,420	28,327
Current liabilities of discontinued operationsno longer reported			1,086	0
Long-Term Debt	19,806	22,736	25,360	30,690	28,745	33,683	34,462	46,750
Deferred Income Taxes	1,702	1,470	1,005R	3,441	1,795	871	1,387	1,439
Other Noncurrent Liabilities	12,041	11,970	12,306R	9,434	8,323	8,792	6,465	7,688
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2025 and 2024	1,788	1,788	1,788	1,788	1,788	1,788	1,788	1,788
Noncurrent Liabilities of Discontinued Operationsno longer reported			186	0
Other paid-in capital	38,808	39,660	39,588	44,238	44,379	44,509	44,704	45,029
Retained earnings	42,579	46,602	47,362	53,696	61,081	53,895	63,069	73,075
Accumulated other comprehensive loss	(5,545)	(6,193)	(6,634)	(4,429)	(4,768)	(5,161)	(4,945)	(4,287)
Stockholders' equity before deduction for treasury stock	77,630	81,857	82,104	95,293	102,480	95,031	104,616	115,605
Less treasury stock, at cost: 1,102,476,756 shares in 2025 and 1,049,466,187 shares in 2024				57,109	56,489	57,450	58,303	62,999
Less treasury stock, at cost: 1,049,499,023 shares in 2021 and 1,046,877,695 shares in 2020no longer reported	50,929	55,950	56,787	57,109
Total Merck & Co., Inc. stockholders equity	26,701	25,907	25,317	38,184	45,991	37,581	46,313	52,606
Noncontrolling Interests	181	94	87	73	67	54	59	56
Total equity	26,882	26,001	25,404	38,257	46,058	37,635	46,372	52,662
Total Liabilities and Equity	82,637	84,397	91,588	105,694	109,160	106,675	117,106	136,866

History starts FY2018, the period ended Dec 31, 2018 — the earliest period our structured-data source covers, not the company’s first year.

42 reported lines · 8 periods · values taken from the latest filing that prints each period.

R21 restated by the filer — hover for the figure as first reported.
italic6 from an earlier filing than the rest of the column.
no longer reported5 lines the filer stopped printing.
— the filer printed the line and left the period empty. An empty cell means the line was not printed at all; it is never a zero.

305 of 305 values link to the exact element in the filer’s own document.

Every line and every caption is the company’s own. Each period carries the value from the latest filing that prints it, which is why a restated period shows the restated number with the figure as first reported kept underneath.

Nothing on this table is computed by us: no fourth quarter, no growth rate, no margin. Marks describe the filer’s own restatements.